(Q54104998)

24 May 2018

title

Effect of ACE gene on diabetic nephropathy in NIDDM patients with insulin resistance. (English)

1 reference

24 May 2018

1 reference

1 reference

Kuramoto N

1

1 reference

24 May 2018

Iizuka T

2

1 reference

24 May 2018

Ito H

3

1 reference

24 May 2018

Yagui K

4

1 reference

24 May 2018

Omura M

5

1 reference

24 May 2018

Nozaki O

6

1 reference

24 May 2018

Nishikawa T

7

1 reference

24 May 2018

Tsuchida H

8

1 reference

24 May 2018

Makino H

9

1 reference

24 May 2018

Saito Y

10

1 reference

24 May 2018

Kanatsuka A

11

1 reference

24 May 2018

publication date

1 February 1999

1 reference

24 May 2018

American Journal of Kidney Diseases

published in

1 reference

24 May 2018

volume

33

1 reference

24 May 2018

issue

2

1 reference

24 May 2018

page(s)

276-281

1 reference

24 May 2018

Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. The Microalbuminuria Captopril Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

Insulin resistance in insulin-dependent diabetic patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

Incipient nephropathy in type 1 (insulin-dependent) diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

Effects of massive obesity on insulin sensitivity and insulin clearance and the metabolic response to insulin as assessed by the euglycemic clamp technique.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

Role of growth hormone in the regulation of insulin sensitivity and lipid metabolism in patients with non insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

End-stage renal disease attributable to diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

Abnormal relation between exchangeable sodium and the renin-angiotensin system in malignant hypertension and in hypertension with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

Inhibition of diabetic nephropathy by a GH antagonist: a molecular analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

Effect of insulin on renal sodium handling in hyperinsulinaemic type 2 (non-insulin-dependent) diabetic patients with peripheral insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

Corcoran Lecture. Sympathetic hyperactivity and coronary risk in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

Insulin resistance, elevated glomerular filtration fraction, and renal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

Cross-talk between the insulin and angiotensin signaling systems

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

Insulin and angiotensin II are additive in stimulating TGF-beta 1 and matrix mRNAs in mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970300-8

7 January 2021

10.1016/S0272-6386(99)70300-8

Identifiers

DOI

1 reference

24 May 2018

release_pydulwo3mbattoisadt3vgttjy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pydulwo3mbattoisadt3vgttjy

24 November 2022

mapped directly with Wikidata item

1 reference

24 May 2018